Christina Annunziata
Medical Oncology · Bethesda, MDNPI 1093084139
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 3 manufacturers reported payments, led by Genentech USA, Inc. at 41.1% of the total. That places this record below the midpoint for medical oncology clinicians in MD, where the typical reported total is $4,199.
Across 3 payments — averaging $121.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$150
- Myriad Genetic Laboratories, Inc.$115
- Eisai Inc.$100
Across 11 payments — averaging $65,484 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$717K
- Amgen$3K
What the payments were for
- Food & beverage$365100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 1 | $150 |
| Myriad Genetic Laboratories, Inc. | 1 | $115 |
| Eisai Inc. | 1 | $100 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- myChoice CDx$115
- LENVIMA$100
How this compares
$365 in reported general payments places this provider in the 30th percentile of 180 medical oncology providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LynparzaOlaparib | 12 | $192,995 |
Paid to pharmacies, not to this prescriber.
Other medical oncology in Bethesda
- Adrian SenderowiczBethesda$1.6M
- Lee HelmanBethesda$43K
- Victor PriegoBethesda$42K
- Christopher KlebanoffBethesda$26K
- Christian HinrichsBethesda$17K
- Mario EisenbergerBaltimore$2.9M
- Mohit NarangOwing Mills$1.3M
- David SidranskyBaltimore$520K
- Carole MillerBaltimore$331K
- Mark LevisBaltimore$323K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.